A resolution designating November 2025 as "National Lung Cancer Awareness Month" and expressing support for early detection and treatment of lung cancer.
- Bill Number
- S.Res. 570
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Passed Senate
- Latest Action
- 2026-01-12: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. (consideration: CR S140; text: CR 12/18/2025 S8925)
- Last Updated
- 2026-01-13T15:37:30Z
AI-Generated Summary
Purpose
This Senate resolution (S. Res. 570) aims to raise awareness about lung cancer, the leading cause of cancer deaths in the U.S., by designating specific periods in November 2025 for education, screening, and support. It highlights the disease's impact, including statistics on diagnoses, deaths, risk factors like smoking and secondhand smoke, and disparities affecting groups such as women, minorities, veterans, and never-smokers. The goal is to promote early detection, treatment, and research to improve survival rates and quality of life.
Key Provisions
- Designations:
- November 2025 as "National Lung Cancer Awareness Month."
- The first week of November 2025 as "National Women's Lung Cancer Awareness Week."
- The second Saturday of November 2025 as "National Lung Cancer Screening Day."
- Support and Promotion:
- Endorses the goals of National Lung Cancer Awareness Month.
- Encourages awareness, education, and research on reducing lung cancer risks (e.g., smoking), screening methods (e.g., low-dose CT scans), treatments (e.g., immunotherapies and targeted therapies), and impacts on minorities and never-smokers.
- Urges biomarker testing and better access to diagnostics, while addressing stigma that hinders diagnosis and research.
- Call to Action:
- Encourages the public, patients, families, and healthcare workers to participate in awareness and educational activities.
Significant Changes to Existing Law
This is a non-binding resolution, so it introduces no legal changes or enforceable requirements. It builds on prior awareness efforts by adding specific 2025 designations but does not amend statutes, regulations, or funding mechanisms.
Potential Impacts
- On Citizens: Increases public knowledge of lung cancer risks, screening (currently only 16% of high-risk individuals are screened), and early detection benefits (e.g., 67% five-year survival for localized cases vs. 12% for advanced). It may reduce stigma, encourage screening among underserved groups (e.g., veterans, where only 3% are screened despite high risk), and promote healthier behaviors like quitting smoking.
- On Government Agencies: No direct mandates, but it could indirectly influence agencies like the Department of Veterans Affairs or Centers for Disease Control and Prevention to prioritize lung cancer programs, education, or barrier reduction (e.g., transportation to screening facilities).
- On International Relations: Minimal impact, as it focuses on U.S.-specific health awareness without addressing global policy or trade.
Main Stakeholders Affected
- At-Risk Populations: Smokers, never-smokers (10-20% of cases), women (higher rates among never-smokers), Black men (highest incidence and mortality), nonwhite individuals (less likely to get early diagnosis), and veterans (25% higher risk, second most common cancer).
- Patients and Families: Those diagnosed (estimated 226,650 in 2025) and affected by 124,730 deaths, benefiting from reduced stigma and better treatment access.
- Healthcare Providers and Researchers: Encouraged to expand screening, education, and innovations like biomarker testing.
- General Public: 62% unaware of screening; resolution promotes broader education to prevent 340 daily deaths.
Notable Legal, Constitutional, or Political Implications
- Legal: As a simple resolution agreed to by the Senate, it has no force of law and requires no presidential approval. It serves as a symbolic gesture without creating rights, obligations, or budgets.
- Constitutional: Aligns with Congress's power to express policy views (Article I) but avoids any establishment of religion or free speech issues, focusing on public health.
- Political: Bipartisan support (introduced by senators from both parties) highlights non-controversial health advocacy. It may signal future legislative priorities, like increased funding for cancer research, but risks being seen as performative without action on barriers like geographic access to care.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (4)
Sen. Capito, Shelley Moore [R-WV], Sen. Hirono, Mazie K. [D-HI], Sen. Reed, Jack [D-RI], Sen. Merkley, Jeff [D-OR]
Recent Actions
- 2026-01-12: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. (consideration: CR S140; text: CR 12/18/2025 S8925)
- 2026-01-12: Passed/agreed to in Senate: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent.
- 2026-01-12: Senate Committee on the Judiciary discharged by Unanimous Consent.
- 2026-01-12: Senate Committee on the Judiciary discharged by Unanimous Consent.
- 2025-12-18: Referred to the Committee on the Judiciary.
- 2025-12-18: Introduced in Senate
Bill Versions
- Designating November 2025 as National Lung Cancer Awareness Month and expressing support for early detection and treatment of lung cancer. — issued 2026-01-12 — PDF (4 pages)